Stock Screener App

Frei -

Installieren

6.36

3.76% 0.25

Design Therapeutics Inc (DSGN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Design Therapeutics Inc-Aktie (DSGN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	5.64% 21.57	20.42	16.69	16.25	15.04
Operating Income/Loss	5.64% -21.57	-20.42	-16.69	-16.25	-15.04
Income/Loss From Continuing Operations Before Tax	7.72% -19.08	-17.71	-13.65	-13.04	-11.79
Income/Loss From Continuing Operations After Tax	7.72% -19.08	-17.71	-13.65	-13.04	-11.79
Net Income/Loss	7.72% -19.08	-17.71	-13.65	-13.04	-11.79
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.18% 56.86	56.76	0.0318	56.62	56.56
Diluted Average Shares	0.18% 56.86	56.76	0.0318	56.62	56.56
Basic Earnings Per Share	9.68% -0.34	-0.31	-0.24	-0.23	-0.21
Diluted Earnings Per Share	9.68% -0.34	-0.31	-0.24	-0.23	-0.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.32

0.98%

GMAB

$27.52

0.51%

SMMT

$25.74

7.94%

BNTX

$110.50

7.16%

INSM

$144.73

1.51%

ONC

$339.41

6.39%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters